Regional Management Corp.
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Rule 10b5-1 Trading Arrangements
The following table lists each “Rule 10b5-1 trading arrangement” (as such term is defined in Item 408(a) of Regulation S-K) that was adopted by a Company officer or director for the sale of shares of Company common stock during the three months ended December 31, 2025. No Rule 10b5-1 trading arrangements were terminated by a Company officer or director during the period.
| Name and Title | Date of Adoption | Termination Date | Maximum Aggregate Number of Securities that may be Sold |
|---|---|---|---|
| Harpreet Rana,EVP, Chief Financial and Administrative Officer | November 20, 2025 | December 31, 2026 | 35,358 (1)(2) |
| Brian J. Fisher,EVP, Chief Strategy & Development Officer | December 10, 2025 | January 31, 2027 | 52,810 (1)(3) |
| Catherine R. Atwood,SVP, General Counsel, and Secretary | November 14, 2025 | December 31, 2026 | 9,000 |
| Steven B. Barnette,VP and Chief Accounting Officer | December 1, 2025 | January 8, 2027 | 7,132 (1)(4) |
(1) The maximum aggregate number of securities that may be sold includes shares of Company common stock that may be withheld by the Company to satisfy income tax withholding and remittance obligations in connection with the net settlement of certain equity awards granted to the officer.
(2) The amount includes (i) the potential sale of up to 17,987 shares of Company common stock plus (ii) the potential exercise of vested stock options and the associated sale of up to 17,371 shares of Company common stock.
(3) The amount includes (i) the potential exercise of vested stock options and the associated sale of up to 28,070 shares of Company common stock, plus (ii) the potential sale of up to 11,762 shares of Company common stock subject to RSAs that vest during the term of the trading arrangement, plus (iii) the potential sale of up to 12,978 PRSUs that vest during the term of the trading arrangement. PRSUs that have not vested and been settled as of February 20, 2026 are assumed to vest at 100% of the target award amount. The actual number of PRSUs that may vest can vary between 0% to 150% of the target award of PRSUs, subject to the achievement of certain performance conditions as set forth in the PRSU award agreement.
(4) The amount includes the potential sale of up to (i) 6,474 shares of Company common stock, plus (ii) 658 shares of Company common stock subject to RSAs that vest during the term of the trading arrangement.
During the three months ended December 31, 2025, none of the Company’s officers or directors adopted or terminated a “non-Rule 10b5-1 trading arrangement” (as such term is are defined in Item 408(a) of Regulation S-K).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.